{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:48:26Z","timestamp":1787806106789,"version":"build-2784847793"},"reference-count":166,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.autrev.2026.104093","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:41:36Z","timestamp":1779464496000},"page":"104093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) guidelines on the use of autoantibody tests in the diagnosis of autoimmune liver diseases"],"prefix":"10.1016","volume":"25","author":[{"given":"Maria Concetta","family":"Sorrentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Villalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Infantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cinquanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Deleonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Platzgummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaola","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunetta","family":"Porcelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Tampoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Antico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Brusca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104093_bb0005","first-page":"261","article-title":"Diagnostica di laboratorio delle epatiti autoimmuni","volume":"6","author":"Villalta","year":"2010","journal-title":"Riv It Med Lab"},{"key":"10.1016\/j.autrev.2026.104093_bb0010","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0015","series-title":"Clinical Practice Guidelines We Can Trust","author":"Graham","year":"2011"},{"key":"10.1016\/j.autrev.2026.104093_bb0020","author":"NACB","year":"2014"},{"key":"10.1016\/j.autrev.2026.104093_bb0025","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2026.104093_bb0030","doi-asserted-by":"crossref","unstructured":"Cappelletti P. Clinical practice guidelines and SIPMeL (Italian Society of Clinical Pathology and Laboratory Medicine) Riv Ital. Med Lab 2015; 11:185-90. [Italian].","DOI":"10.1007\/s13631-015-0104-4"},{"key":"10.1016\/j.autrev.2026.104093_bb0035","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jgh.14746","article-title":"Systematic review and metanalysis on the incidence and prevalence of autoimmune hepatitis in Asian, European and American population","volume":"34","author":"Lv","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104093_bb0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12016-010-8236-9","article-title":"Cutting edge issue in autoimmune hepatitis","volume":"42","author":"Vergani","year":"2012","journal-title":"Clin Rev Allerg Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"International Autoimmune Hepatitis Group. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0060","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0065","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jhep.2023.01.013","article-title":"Long-term outcomes of patients with type 1 or 2 autoimmune hepatitis presenting in childhood","volume":"78","author":"Maggiore","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0070","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jhep.2023.02.017","article-title":"Paediatric autoimmune hepatitis: time to change the textbooks?","volume":"78","author":"Lohse","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104093_bb0085","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.29.5.403","article-title":"Classification of smooth muscle autoantibodies detected by immunofluorescence","volume":"29","author":"Bottazzo","year":"1976","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2026.104093_bb0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.autrev.2012.04.005","article-title":"Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found","volume":"12","author":"Rigopoulou","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104093_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.07.021","article-title":"Autoantibodies to asialoglycoprotein receptor (ASGPR) in patients with autoimmune liver diseases","volume":"450","author":"Villalta","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2026.104093_bb0100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.510280207","article-title":"Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins","volume":"28","author":"Terjung","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0105","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"P-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104093_bb0110","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0016-5085(95)90215-5","article-title":"High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis","volume":"108","author":"Targan","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104093_bb0115","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adult and children: 2019 practice guidance and guidelines from American Association for the Study of Liver Diseases (AASLD)","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhep.2020.07.032","article-title":"Update of the simplified criteria for autoimmune hepatitis: evaluation of the methodology for immunoserological testing","volume":"74","author":"Galaski","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2013-204793","article-title":"Detection of antinuclear antibodies: added value of solid phase assay?","volume":"73","author":"Bossuyt","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.autrev.2017.12.007","article-title":"The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases","volume":"17","author":"Bizzaro","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104093_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-214805","article-title":"Can solid-phase assays replace immunofluorescence for ANA screening?","volume":"79","author":"Bizzaro","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-215443","article-title":"Antinuclear antibodies by indirect immunofluorescence and solid phase assays","volume":"79","author":"Bossuyt","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-022-02980-x","article-title":"Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases","volume":"24","author":"Bizzaro","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2026.104093_bb0150","first-page":"1","article-title":"Is immunofluorescence about to disappear in clinical laboratories?","volume":"19","author":"Bizzaro","year":"2023","journal-title":"Riv It Med Lab"},{"key":"10.1016\/j.autrev.2026.104093_bb0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jalm\/jfab132","article-title":"Detecting autoantibodies by multiparametric assays: impact on prevention, diagnosis, monitoring, and personalized therapy in autoimmune diseases","volume":"7","author":"Cinquanta","year":"2022","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.autrev.2026.104093_bb0160","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","article-title":"Pregnancy in autoimmune hepatitis: outcome and risk factors","volume":"101","author":"Schramm","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0165","article-title":"Anti-nuclear antibody screening using HEp-2 cells","volume":"88","author":"Buchner","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.autrev.2026.104093_bb0170","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclearantibodies in \u2018healthy\u2019 individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0175","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/000992280404300709","article-title":"Frequency of antinuclear antibodies in healthy children and adolescents","volume":"43","author":"Hil\u00e1rio","year":"2004","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.autrev.2026.104093_bb0180","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12016-016-8579-y","article-title":"Challenges in the standardization of autoantibody testing: a comprehensive review","volume":"53","author":"Tozzoli","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0185","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510260306","article-title":"Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1 autoimmune hepatitis","volume":"26","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104093_bb0195","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1515\/cclm-2023-0209","volume":"61","author":"Bonroy","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2026.104093_bb0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s13631-015-0099-x","article-title":"Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Revision 2015","volume":"11","author":"Cinquanta","year":"2015","journal-title":"Riv Ital Med Lab"},{"key":"10.1016\/j.autrev.2026.104093_bb0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8278(00)80425-0","article-title":"Autoimmune hepatitis","volume":"32","author":"Obermayer-Straub","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/08916930701619227","article-title":"Serum autoantibodies: a road map for the clinical hepatologist","volume":"41","author":"Meda","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2026.104093_bb0215","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/0891693021000054066","article-title":"Smooth muscle antibodies and type 1 autoimmune hepatitis","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2026.104093_bb0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejim.2017.10.006","article-title":"Serology in autoimmune hepatitis: a clinical-practice approach","volume":"48","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2026.104093_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08916930701619896","article-title":"Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders","volume":"41","author":"Villalta","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2026.104093_bb0230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jcp.2005.027367","article-title":"Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis","volume":"59","author":"Granito","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2026.104093_bb0235","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1572-0241.2007.01180_7.x","article-title":"Antifilamentous actin antibodies by ELISA for the diagnosis of type 1 autoimmune hepatitis","volume":"102","author":"Granito","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0240","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position Statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.autrev.2026.104093_bb0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jcla.21813","article-title":"Autoantibody profiling in a cohort of pediatric and adult patients with autoimmune hepatitis","volume":"30","author":"Villalta","year":"2014","journal-title":"J Clin Lab Analysis"},{"key":"10.1016\/j.autrev.2026.104093_bb0250","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/00313025.2010.493867","article-title":"Actin-reactive discriminated from non-actin-reactive smooth muscle auto-antibody by immunofluorescence reactivity with rat epithelial cell line","volume":"42","author":"Toh","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.autrev.2026.104093_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis: contrast and comparison in children and adults-a comprehensive review","volume":"46","author":"Floreani","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104093_bb0260","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0265","first-page":"331","article-title":"Microsomal antibodies in active chronic hepatitis and other disorders","volume":"15","author":"Rizzetto","year":"1973","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0270","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.168.2.801","article-title":"Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily","volume":"168","author":"Gueguen","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2026.104093_bb0275","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/bmj.2.5910.80","article-title":"Hepatic disorders associated with liver-kidney microsomal antibodies","volume":"2","author":"Smith","year":"1974","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2026.104093_bb0280","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/hep.1840040223","article-title":"Ticrynafen-associated hepatic injury: analysis of 340 cases","volume":"4","author":"Zimmerman","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0285","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(94)91966-6","article-title":"Recognition of uridine diphosphateglucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D","volume":"344","author":"Philipp","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104093_bb0290","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2249.1994.tb06585.x","article-title":"Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection","volume":"97","author":"Ma","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0295","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gut.37.3.406","article-title":"Heterogeneity of liver kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease","volume":"37","author":"Muratori","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104093_bb0300","first-page":"1","article-title":"Contemporary issues and future directions in autoimmune hepatitis","volume":"3","author":"Liberal","year":"2016","journal-title":"Exp Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0305","first-page":"232","article-title":"Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent","volume":"54","author":"Crivelli","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0310","first-page":"561","article-title":"A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis","volume":"55","author":"Homberg","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0315","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","article-title":"Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis","volume":"111","author":"Strassburg","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104093_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1568-9972(03)00051-X","article-title":"Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis","volume":"3","author":"Fabien","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104093_bb0325","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","article-title":"Frequency and significance of antibodies to liver\/kidney microsome type 1 in adults with chronic active hepatitis","volume":"103","author":"Czaja","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104093_bb0330","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1515\/cclm-2022-1136","article-title":"Comparison of ANA testing by indirect immunofluorescence or solid-phase assays in a low pre-test probability population for systemic autoimmune disease: the Camargo Cohort","volume":"61","author":"Martinez-Revuelta","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2026.104093_bb0335","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104093_bb0340","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.1173755","article-title":"The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation","volume":"325","author":"Palioura","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.autrev.2026.104093_bb0345","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5009\/gnl15352","article-title":"Diagnosis and management of autoimmune hepatitis: current status and future directions","volume":"10","author":"Czaja","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.autrev.2026.104093_bb0350","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion","volume":"89","author":"Gelpi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2026.104093_bb0355","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0360","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s10620-010-1268-4","article-title":"Autoantibodies as prognostic markers in autoimmune liver disease","volume":"55","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2026.104093_bb0365","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1016\/S0168-8278(07)62258-2","article-title":"Antibody responses specific for soluble liver antigen co-occur with RO-52 autoantibodies in patients with autoimmune hepatitis","volume":"46","author":"Liaskos","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0370","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1478-3231.2009.01986.x","article-title":"Significance of antibodies to soluble liver antigen\/liver pancreas: a large French study","volume":"29","author":"Eyraud","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2026.104093_bb0375","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/liv.12658","article-title":"Anti-SLA\/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis","volume":"35","author":"Zachou","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2026.104093_bb0380","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0385","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/liv.14280","article-title":"Permanent immunosuppression in SLA\/LP-positive autoimmune hepatitis is required although overall response and survival are similar","volume":"40","author":"Zachou","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2026.104093_bb0390","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1478-3231.2011.02502.x","article-title":"Prognostic implications of antibodies to Ro\/SSA and soluble liver antigen in type 1 autoimmune hepatitis","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2026.104093_bb0395","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0400","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104093_bb0405","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0410","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104093_bb0415","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3748\/wjg.15.2314","article-title":"Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment","volume":"15","author":"Czaja","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0420","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2026.104093_bb0425","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104093_bb0430","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2249.2001.01682.x","article-title":"Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation","volume":"126","author":"Aguilera","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0435","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jhep.2015.06.031","article-title":"Changing nomenclature for PBC: from \u2018cirrhosis\u2019 to \u2018cholangitis\u2019. American Association for the Study of Liver Diseases","volume":"63","author":"Beuers","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0440","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2005-916319","article-title":"Genetics and geoepidemiology of primary biliary cirrhosis; following the footprints to disease etiology","volume":"25","author":"Selmi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0445","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104093_bb0450","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/gene.2012.17","article-title":"Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis","volume":"13","author":"Invernizzi","year":"2012","journal-title":"Genes Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0455","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104093_bb0460","first-page":"485","article-title":"Primary biliary cholangitis: a comprehensive overview","volume":"6","author":"Lleo","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2026.104093_bb0465","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0470","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0475","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","article-title":"Positive antimitochondrial antibody but normal alkaline phosphatase: Is this primary biliary cirrhosis?","volume":"6","author":"Mitchison","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0480","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s005350170111","article-title":"The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples","volume":"36","author":"Kisand","year":"2001","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0485","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510250103","article-title":"Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression","volume":"25","author":"Van Norstrand","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0490","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-2008-1040503","article-title":"Identification and characterization of four M2 mitochondrial autoantigens in primary biliary cirrhosis","volume":"9","author":"Bassendine","year":"1989","journal-title":"Sem Liver Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0495","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cld.2008.02.003","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis","volume":"12","author":"Hirschfield","year":"2008","journal-title":"Clin Liv Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0500","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1478-3231.2007.01651.x","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis","volume":"28","author":"Liu","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2026.104093_bb0505","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12016-010-8234-y","article-title":"Overcoming a \u201cprobable\u201d diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature","volume":"42","author":"Bizzaro","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0510","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0515","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/liv.12690","article-title":"Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis","volume":"35","author":"Norman","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.autrev.2026.104093_bb0520","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2012.02.013","article-title":"Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis","volume":"12","author":"Op De Be\u00e9ck","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104093_bb0525","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/cgh.2003.50014","article-title":"When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?","volume":"1","author":"Zein","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0530","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","article-title":"Diagnosis and management of primary biliary cholangitis","volume":"114","author":"Younossi","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0535","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/gut.22.2.136","article-title":"Is mitochondrial antibody diagnostic of primary biliary cirrhosis?","volume":"22","author":"Munoz","year":"1981","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104093_bb0540","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8278(86)80015-0","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis","volume":"2","author":"Berg","year":"1986","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0545","doi-asserted-by":"crossref","unstructured":"Mackay IR, Gershwin ME. The autoantibodies of primary biliary cirrhosis: clinico-pathological correlations. In: van Venrooj WJ and Maini RN (eds). Manual of biological markers of disease. Dordrecht: Kluwer Academic Publishers, 1996; C8.1:18.","DOI":"10.1007\/978-94-011-1670-1_48"},{"issue":"8594","key":"10.1016\/j.autrev.2026.104093_bb0550","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(88)91894-6","article-title":"Primary biliary cirrhosis: identification of two major m2 mitochondrial autoantigens","volume":"331","author":"Yeaman","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104093_bb0555","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.1840090110","article-title":"Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain a-keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kD mitochondria1 autoantigen","volume":"9","author":"Surh","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0560","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2007-1007183","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis","volume":"17","author":"Leung","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0565","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13317-012-0038-z","article-title":"Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies","volume":"3","author":"Milkiewicz","year":"2012","journal-title":"Autoimmun Highlights"},{"key":"10.1016\/j.autrev.2026.104093_bb0570","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.510240117","article-title":"Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies","volume":"24","author":"Moteki","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0575","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s005350170151","article-title":"High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis","volume":"36","author":"Miyakawa","year":"2001","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0580","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"\u2018True\u2019 antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0585","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1515\/cclm-2019-1210","article-title":"How reliable is the detection of anti-mitochondrial antibodies on murine triple-tissue?","volume":"58","author":"Porcelli","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2026.104093_bb0590","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.dld.2023.04.011","article-title":"Incidental finding of anti-mitochondrial antibody: A neglected entity needing reappraisal","volume":"55","author":"Porcelli","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0595","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis","volume":"98","author":"Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0600","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0605","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0610","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1074\/mcp.M111.015529","article-title":"Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays","volume":"11","author":"Hu","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.autrev.2026.104093_bb0615","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1515\/cclm-2020-0122","article-title":"Evaluation of a novel extended automated particle-based muli-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis","volume":"58","author":"Villalta","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2026.104093_bb0620","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.14309\/ajg.0000000000000690","article-title":"Novel anti-hexokinase 1 antibodies are associated with poor prognosis in patients with primary biliary cholangitis","volume":"115","author":"Reig","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0625","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104093_bb0630","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/hepr.12423","article-title":"Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.autrev.2026.104093_bb0635","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1089-3261(03)00104-1","article-title":"Antimitochondrial and other autoantibodies","volume":"7","author":"Bogdanos","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0640","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1515\/cclm-2023-0742","article-title":"Diagnostic and prognostic value of iFlash-AMA-M2 in PBC","volume":"62","author":"Wang","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2026.104093_bb0645","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MOG.0b013e3282f9e239","article-title":"An update on primary sclerosing cholangitis","volume":"24","author":"Maggs","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0650","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis \u2013 a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0655","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3748\/wjg.v13.i41.5421","article-title":"Genetic epidemiology of primary sclerosing cholangitis","volume":"13","author":"Karlsen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0660","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","article-title":"Genetics of primary sclerosing cholangitis and pathophysiological implications","volume":"14","author":"Jiang","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0665","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.autrev.2026.104093_bb0670","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0675","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2026.104093_bb0680","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0685","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0690","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0695","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0700","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0168-8278(00)80241-X","article-title":"Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases","volume":"32","author":"Roozendaal","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0705","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-008-8088-8","article-title":"Atypical p-ANCA in PSC and AIH: a hint toward a \u201cleaky gut\u201d?","volume":"36","author":"Terjung","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0710","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u201cAtypical p-ANCA\u201d in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2026.104093_bb0715","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2249.2001.01649.x","article-title":"Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy","volume":"126","author":"Terjung","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2026.104093_bb0720","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/liv.13238","article-title":"Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis","volume":"37","author":"Hov","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2026.104093_bb0725","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2026.104093_bb0730","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2026.104093_bb0735","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ecco-jcc\/jjv087","article-title":"Rediscovery of the anti-pancreatic antibodies and evaluation of their prognostic value in a prospective clinical cohort of Crohn\u2019s patients: the importance of specific target antigens [GP2 and CUZD1]","volume":"9","author":"Papp","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2026.104093_bb0740","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gutjnl-2016-311739","article-title":"Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis","volume":"66","author":"Jendrek","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104093_bb0745","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-230X-9-58","article-title":"The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli type 1 fimbriae","volume":"9","author":"Yu","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.autrev.2026.104093_bb0750","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature08529","article-title":"Uptake through glycoprotein 2 of FimH + bacteria by M cells initiates mucosal immune response","volume":"462","author":"Hase","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104093_bb0755","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104093_bb0760","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104093_bb0765","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis","volume":"66","author":"R\u00fchlemann","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2026.104093_bb0770","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112877","article-title":"P3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)","volume":"9","author":"Stinton","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2026.104093_bb0775","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MPG.0000000000003359","article-title":"Anti-proteinase 3 antibodies as a biomarker for ulcerative colitis and primary sclerosing cholangitis in children","volume":"74","author":"Laass","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.autrev.2026.104093_bb0780","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3390\/diagnostics12112682","article-title":"PR-3 ANCAs detected by third-generation ELISA predicts severe disease and poor survival in primary sclerosing cholangitis","volume":"12","author":"Lopens","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.autrev.2026.104093_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2025.100197","article-title":"From thrombosis to transplantation: The role of anti-phospholipid antibodies in liver disease management","volume":"4","author":"Pallotta","year":"2025","journal-title":"ILIVER"},{"key":"10.1016\/j.autrev.2026.104093_bb0790","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15403\/jgld.2014.1121.amb","article-title":"Autoimmune liver diseases and antiphospholipid antibodies positivity: a meta-analysis of literature studies","volume":"24","author":"Ambrosino","year":"2015","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.autrev.2026.104093_bb0795","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaut.2005.01.016","article-title":"Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis","volume":"24","author":"Liaskos","year":"2005","journal-title":"J Autoimmun"},{"issue":"SI","key":"10.1016\/j.autrev.2026.104093_bb0805","doi-asserted-by":"crossref","first-page":"SI4","DOI":"10.1093\/rheumatology\/kead603","article-title":"Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?","volume":"63","author":"Raschi","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104093_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2026.02.018","article-title":"The many pathways driving liver inflammation in MASH","author":"Tilg","year":"2026","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2026.104093_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103112","article-title":"mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency","volume":"140","author":"Winans","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2026.104093_bb0820","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.autrev.2012.02.011","article-title":"The clinical autoimmunologist and the laboratory autoimmunologist: The two sides of the coin","volume":"11","author":"Tozzoli","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104093_bb0825","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13317-020-00133-1","article-title":"The clinical and the laboratory autoimmunologist: Where do we stand?","volume":"11","author":"Tozzoli","year":"2020","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.autrev.2026.104093_bb0830","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12026-013-8418-7","article-title":"Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist","volume":"56","author":"Tozzoli","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2026.104093_bb0835","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1628478","article-title":"Immunological and clinical overlap between autoimmune gastritis and autoimmune liver diseases: a prospective cohort study","volume":"16","author":"Massironi","year":"2025","journal-title":"Front Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:44:54Z","timestamp":1785167094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226001072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":166,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1568997226001072"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104093","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) guidelines on the use of autoantibody tests in the diagnosis of autoimmune liver diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104093"}}